摘要
针对我国医药行业创新能力弱的问题,借鉴美国的经验,认为较高的创新获利能力不仅有助于医药行业加大研发投入,还有利于吸引各类资金投入,有利于完善产学研合作研发体系。因此,强化创新获利能力是提升我国医药行业创新能力的关键。同时,还应加大政府支持力度,共同引导我国医药行业进入创新推动的良性循环。
To enhance innovation ability of pharmaceuticals industry in China, this paper strongly emphasizes the ability for innovation to make a profit. Learning from American experience, the ability for innovation to make a profit either lead to more money into R＆D or lead to more integration of production, teaching and research. So strengthening this ability is the key to enhance innovation ability of pharmaceuticals industry in China.
出处
《上海经济研究》
CSSCI
北大核心
2009年第11期14-20,共7页
Shanghai Journal of Economics
关键词
医药行业
美国经验
创新获利
对策
pharmaceuticals industry, American experience, the ability for innovation to make a profit, countermeasure
